D.A. Spandidos
- Label
- D.A. Spandidos (literal)
- D.A. Spandidos (literal)
- Editore di
- Androgen deprivation therapy affects BCL-2 expression in human prostate cancer (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Simvastatin reduces melanoma progression in a murine model (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Regulation of the expression of CLU isoforms in endometrial proliferative diseases (Articolo in rivista) (Prodotto della ricerca)
- Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of the major histocompatibility complex class II (MHC II) engagement and of the meso-tetra(4-sulfonatophenyl) porphynate derivatives on melanoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Preferred label
- D.A. Spandidos, Athens (GRC) (literal)
- D.A. Spandidos, Athens (GRC) (literal)
Incoming links:
- Editore
- Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Androgen deprivation therapy affects BCL-2 expression in human prostate cancer (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of the major histocompatibility complex class II (MHC II) engagement and of the meso-tetra(4-sulfonatophenyl) porphynate derivatives on melanoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Simvastatin reduces melanoma progression in a murine model (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Regulation of the expression of CLU isoforms in endometrial proliferative diseases (Articolo in rivista) (Prodotto della ricerca)